JPC
ORGO icon

Jabodon PT Co’s Organogenesis Holdings ORGO Stock Holding History

Jabodon PT Co’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-265,087
Closed -$2.02M – 20
2022
Q1 		$2.02M Sell
265,087
-1,986
-0.7% -$15.4K 0.92% 30
2021
Q4 		$2.47M Buy
267,073
+4,892
+2% +$52K 1.13% 30
2021
Q3 		$3.73M Buy
+262,181
New +$4.07M 1.55% 23

Other funds holding ORGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jabodon PT Co's ORGO Position: Q2 2022 in Review

Jabodon PT Co sold out of Organogenesis Holdings (ORGO) in Q2 2022, closing a stake of 265,087 shares — an estimated $2.02M sold.

Jabodon PT Co first reported a position in ORGO in Q3 2021 and held it in 3 quarters. The position peaked at $3.73M in Q3 2021. 146 funds tracked by Wall St. Rank hold ORGO as of Q2 2022.

  • Jabodon PT Co reported no remaining Organogenesis Holdings position as of Q2 2022 after selling out during the quarter.
  • Jabodon PT Co sold 265,087 Organogenesis Holdings shares in Q2 2022, an estimated $2.02M.
  • Jabodon PT Co first reported a position in Organogenesis Holdings in Q3 2021 and held it in 3 quarters.
  • Jabodon PT Co's Organogenesis Holdings position peaked at $3.73M in Q3 2021.
  • 146 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2022.

Based on Jabodon PT Co's 13F filing for Q2 2022, filed 12 Aug 2022.